Sarepta Therapeutics (SRPT)
(Delayed Data from NSDQ)
$116.55 USD
-1.34 (-1.14%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $116.53 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/7/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | 0.47 |
Last EPS Surprise | 1,666.67% |
ABR | 1.50 |
Earnings ESP
|
123.86% |
---|---|
Current Year | 2.14 |
Next Year | 8.10 |
EPS (TTM) | -1.23 |
P/E (F1) | 54.98 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 370.93M | 381.12M | 1.81B | 2.75B |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 403.76M | 420.76M | 2.37B | 4.23B |
Low Estimate | 299.50M | 286.50M | 1.51B | 1.67B |
Year ago Sales | 253.50M | 261.24M | 1.24B | 1.81B |
Year over Year Growth Est. | 46.32% | 45.89% | 45.96% | 51.63% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | 0.16 | 2.14 | 8.10 |
# of Estimates | 7 | 6 | 7 | 8 |
Most Recent Consensus | -0.35 | 0.04 | 0.93 | 5.28 |
High Estimate | 0.13 | 1.02 | 6.74 | 17.69 |
Low Estimate | -0.62 | -0.47 | -0.60 | -1.64 |
Year ago EPS | -0.97 | -0.27 | -5.80 | 2.14 |
Year over Year Growth Est. | 86.60% | 159.26% | 136.90% | 278.13% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 2 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 4 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | 0.16 | 2.14 | 8.10 |
7 Days Ago | -0.12 | 0.16 | 2.14 | 8.10 |
30 Days Ago | -0.14 | 0.12 | 1.94 | 8.22 |
60 Days Ago | -0.01 | 0.67 | 2.47 | 9.43 |
90 Days Ago | -0.01 | 0.48 | 2.44 | 9.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.03 | 0.16 | 2.14 | 8.10 |
Zacks Consensus Estimate | -0.13 | 0.16 | 2.14 | 8.10 |
Earnings ESP | 123.86% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.47 | -0.46 | -0.27 | -0.97 | NA |
Estimate | -0.03 | -1.66 | -1.89 | -1.46 | NA |
Difference | 0.50 | 1.20 | 1.62 | 0.49 | 0.95 |
Surprise | 1,666.67% | 72.29% | 85.71% | 33.56% | 464.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more